Loading Page
Dr. Matthew M. Heeney, MD is a pediatric oncologist in BOSTON, MA specializing in pediatric hematology/oncology. He graduated from University of Calgary Faculty of Medicine. Dr. Matthew M. Heeney, MD is affiliated with Dana-Farber Cancer Institute and Boston Medical Center.
Dr. Matthew M. Heeney, MD graduated from University of Calgary Faculty of Medicine. He completed residency at The Montreal Children's Hospital. He is certified by the Board Certification: Pediatric Hematology/Oncology and Pediatrics and has a state license in Massachusetts.
Medical School: University of Calgary Faculty of Medicine
Residency: The Montreal Children's Hospital
Board Certification: Board Certification: Pediatric Hematology/Oncology and Pediatrics
Licensed In: Massachusetts
Dr. Matthew M. Heeney, MD does not have any reviews yet, be the first to leave a review of Dr. Matthew M. Heeney, MD here: Leave a Review
These charts describe general payments received by Dr. Matthew M. Heeney, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$50,663
CRIZANLIZUMAB $15,269 |
ADAKVEO $12,667 |
Exjade $980 |
$21,747 |
||
|
$49,282
BRILINTA $14,854 |
$34,428 |
||||
|
$35,828
$35,828 |
|||||
|
$22,964
Effient $15,890 |
$7,074 |
||||
|
$14,156
OXBRYTA $7,771 |
$6,385 |
||||
|
$34,737
OXBRYTA $7,019 |
BRILINTA $5,360 |
DOPTELET $4,248 |
PYRUKYND $3,392 |
$14,717 |
| $122,811 | |
| $53,961 | |
| $12,565 | |
| $11,998 | |
| $4,795 | |
| $1,500 |
Dr. Matthew M. Heeney, MD has received 77 research payments totaling $974,489.
Matthew Heeney, MD, is board certified in pediatrics and pediatric hematology/oncology. He is the Associate Chief for Hematology in the Division of Hematology/Oncology and the Director of the Sickle Cell Program in Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dr Heeney's research interests are focused on sickle cell disease and congenital disorders of iron metabolism. The goals of Dr Heeney's research include improving the understanding of the pathophysiology and treatment of sickle cell anemia through clinical investigation and elucidating the genetic basis of iron homeostasis and its role in human disease.
